Science - Biotechnologies latest news

MELBOURNE, AUSTRALIA and AUCKLAND, NEW ZEALAND (MARKET WIRE) Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced that Australian television Channel Ten News will feature the Company's world first islet cell treatment being developed for insulin dependent diabetes on its news segment between 5:00pm - 6:00pm this evening.

MELBOURNE, AUSTRALIA and AUCKLAND, NEW ZEALAND (MARKET WIRE) Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced it has applied to list its American Depository Receipt (ADR) program on the International OTCQX to increase the Company's exposure to U.S. investors.

CARDIFF, CA (MARKET WIRE) NI Research announces the publication of CNS 2008: Disorders/Therapeutics. The 2008 edition of this incomparable CNS industry overview incorporates a first-in-class evaluation of Big Pharma licensing skills and styles; Big Pharma Report Card: Business Development.

NORWOOD, MA (MARKET WIRE) Apogee Technology, Inc. (OTCBB: ATCS) today announced an agreement with Hebrew SeniorLife's Institute for Aging Research (IFAR) in Boston, Massachusetts, to conduct studies designed to evaluate Apogee's IntellaPAL(TM) health monitoring system and to better assess fall-related health conditions in older adults. IFAR is an internationally recognized leader in aging research and a teaching affiliate of Beth Israel Deaconess Medical Center and Harvard Medical School.

The pain patch on which BioDelivery Sciences International has bet its future came up a winner in its latest round of human testing, the Raleigh drug company said Thursday.

MONTREAL, QUEBEC (MARKET WIRE) Adaltis Inc. (TSX: ADS), an international in vitro diagnostic company, today held its annual meeting of shareholders at which it highlighted progress on its execution plan, specifically on the important steps forward taken to become a leading provider of immunoassay diagnostic systems in emerging markets, specifically focusing on China. Adaltis President and Chief Executive Officer, Pierre Larochelle, updated shareholders on the key decisions taken and implemented over the past year to accelerate the transition of Adaltis into a China-based company.

REDWOOD CITY, CA (MARKET WIRE) PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the quarter ended March 31, 2008. The results of the company's commercial and cardiovascular operations segment are presented as discontinued operations. The assets related to this segment were sold in March 2008. The financial results for continuing and discontinued operations are summarized below and are included, in addition to supplemental information, in the financial tables accompanying this press release.

MEDFORD, NY (MARKET WIRE) Chembio Diagnostics, Inc. (OTCBB: CEMI), a developer and manufacturer of rapid diagnostic tests for infectious diseases, announced today that the company will release financial results for the first quarter ended March 31, 2008, following the close of the market on Monday, May 12, 2008.

Quintiles Transnational will add to its fast-growing consulting business after signing an agreement to purchase Boston-based Eidetics.

MONTREAL, CANADA (MARKET WIRE) Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, will release its first quarter financial results on Thursday, May 15, 2008 prior to market opening. Following the release, Paladin will hold a conference call at 10:00 a.m. (EST) hosted by Jonathan Ross Goodman, President and CEO of Paladin Labs. Paladin cordially invites all interested parties to participate in this call.